INTELLIA THERAPEUTICS, INC. (NTLA) Capital expenditures 2016–2025
INTELLIA THERAPEUTICS, INC. (NTLA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.1MFY2025 · since FY2016: $6.2M → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1M | -80.5% |
| FY2024 | $5.8M | -58.7% |
| FY2023 | $14.0M | +3.1% |
| FY2022 | $13.6M | +6.3% |
| FY2021 | $12.8M | +255.8% |
| FY2020 | $3.6M | -47.2% |
| FY2019 | $6.8M | +6.9% |
| FY2018 | $6.4M | -37.0% |
| FY2017 | $10.1M | +63.7% |
| FY2016 | $6.2M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice